FI950439A - 3'-atsido-3'-deoksitymidiinin kontrolloidusti vapauttavat farmaseuttiset valmisteet ja käyttömenetelmät - Google Patents
3'-atsido-3'-deoksitymidiinin kontrolloidusti vapauttavat farmaseuttiset valmisteet ja käyttömenetelmät Download PDFInfo
- Publication number
- FI950439A FI950439A FI950439A FI950439A FI950439A FI 950439 A FI950439 A FI 950439A FI 950439 A FI950439 A FI 950439A FI 950439 A FI950439 A FI 950439A FI 950439 A FI950439 A FI 950439A
- Authority
- FI
- Finland
- Prior art keywords
- deoxythymidine
- controlled release
- pct
- azt
- azido
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92447692A | 1992-08-04 | 1992-08-04 | |
PCT/US1993/007308 WO1994003471A1 (en) | 1992-08-04 | 1993-08-04 | Controlled release pharmaceutical formulations of 3'-azido-3'-deoxythymidine and methods of use |
Publications (2)
Publication Number | Publication Date |
---|---|
FI950439A true FI950439A (fi) | 1995-02-01 |
FI950439A0 FI950439A0 (fi) | 1995-02-01 |
Family
ID=25450250
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI950439A FI950439A0 (fi) | 1992-08-04 | 1995-02-01 | 3'-atsido-3'-deoksitymidiinin kontrolloidusti vapauttavat farmaseuttiset valmisteet ja käyttömenetelmät |
Country Status (8)
Country | Link |
---|---|
US (1) | US5681581A (fi) |
EP (1) | EP0654038B1 (fi) |
AT (1) | ATE186544T1 (fi) |
AU (1) | AU677220B2 (fi) |
CA (1) | CA2141788C (fi) |
DE (1) | DE69327004T2 (fi) |
FI (1) | FI950439A0 (fi) |
WO (1) | WO1994003471A1 (fi) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5580578A (en) * | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
US7070806B2 (en) * | 1992-01-27 | 2006-07-04 | Purdue Pharma Lp | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
US5851579A (en) * | 1996-10-28 | 1998-12-22 | Eastman Chemical Company | Aqueous enteric coating compositions |
US6576231B2 (en) * | 1997-09-12 | 2003-06-10 | Schering Ag | Methods for treating HIV-Infected Patients by the Administration of GM-CSF and a protease inhibitor |
US6309632B1 (en) | 1998-04-28 | 2001-10-30 | Immunex Corporation | Methods for treating HIV-infected patients by administering GM-CSF |
JP2003508420A (ja) | 1999-09-02 | 2003-03-04 | ノストラム・ファーマスーティカルズ・インコーポレイテッド | 経口投与に適した、制御された放出の経口用量 |
US20030050620A1 (en) * | 2001-09-07 | 2003-03-13 | Isa Odidi | Combinatorial type controlled release drug delivery device |
CZ20041117A3 (cs) * | 2002-04-23 | 2005-04-13 | Lupin Limited | Dlouhodobě působící kompozice zahrnující zidovudin a lamivudin |
WO2004043433A2 (en) * | 2002-11-08 | 2004-05-27 | Glaxo Group Limited | Pharmaceutical antiviral compositions |
CA2529984C (en) | 2003-06-26 | 2012-09-25 | Isa Odidi | Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors |
US8394409B2 (en) | 2004-07-01 | 2013-03-12 | Intellipharmaceutics Corp. | Controlled extended drug release technology |
US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
EP2007360B1 (en) | 2006-04-03 | 2014-11-26 | Isa Odidi | Controlled release delivery device comprising an organosol coat |
US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
WO2009037449A1 (en) * | 2007-09-18 | 2009-03-26 | Cipla Limited | Solid pharmaceutical compositions comprising one or more herpes virus inhibitors and one or more reverse transcriptase inhibitors |
US10940113B2 (en) * | 2017-02-24 | 2021-03-09 | Medical And Pharmaceutical Industry Technology And Development Center | Pharmaceutical composition for colon targeting, method for treating a colon-related disease using the same and preparation method thereof |
GB2595203A (en) | 2020-03-03 | 2021-11-24 | Alkaloid Ad Skopje | Formulation |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL78826A (en) * | 1986-05-19 | 1991-05-12 | Yissum Res Dev Co | Precursor composition for the preparation of a biodegradable implant for the sustained release of an active material and such implants prepared therefrom |
ATE71293T1 (de) * | 1986-09-18 | 1992-01-15 | London Pharmacy Innovation | Arzneiformulierung. |
GB8706176D0 (en) * | 1987-03-16 | 1987-04-23 | Wellcome Found | Therapeutic nucleosides |
GB8707421D0 (en) * | 1987-03-27 | 1987-04-29 | Wellcome Found | Pharmaceutical formulations |
-
1993
- 1993-08-04 WO PCT/US1993/007308 patent/WO1994003471A1/en active IP Right Grant
- 1993-08-04 EP EP93918622A patent/EP0654038B1/en not_active Expired - Lifetime
- 1993-08-04 CA CA002141788A patent/CA2141788C/en not_active Expired - Fee Related
- 1993-08-04 DE DE69327004T patent/DE69327004T2/de not_active Expired - Fee Related
- 1993-08-04 AU AU48015/93A patent/AU677220B2/en not_active Ceased
- 1993-08-04 US US08/379,472 patent/US5681581A/en not_active Expired - Fee Related
- 1993-08-04 AT AT93918622T patent/ATE186544T1/de not_active IP Right Cessation
-
1995
- 1995-02-01 FI FI950439A patent/FI950439A0/fi unknown
Also Published As
Publication number | Publication date |
---|---|
ATE186544T1 (de) | 1999-11-15 |
FI950439A0 (fi) | 1995-02-01 |
AU4801593A (en) | 1994-03-03 |
DE69327004D1 (de) | 1999-12-16 |
EP0654038A4 (en) | 1996-02-28 |
AU677220B2 (en) | 1997-04-17 |
EP0654038B1 (en) | 1999-11-10 |
CA2141788A1 (en) | 1994-02-17 |
CA2141788C (en) | 2001-12-11 |
EP0654038A1 (en) | 1995-05-24 |
DE69327004T2 (de) | 2000-06-29 |
WO1994003471A1 (en) | 1994-02-17 |
US5681581A (en) | 1997-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI950439A0 (fi) | 3'-atsido-3'-deoksitymidiinin kontrolloidusti vapauttavat farmaseuttiset valmisteet ja käyttömenetelmät | |
RS49577B (sr) | Formulacije analoga insulina | |
BR9910180A (pt) | Composição farmacêutica, processos para o tratamento de uma condição associada com a transmissão reduzida de nicotina, para identificação de um modulador positivo de um agonista receptor nicotìnico e para identificação de um composto, composto, e, uso de um modulador positivo de um agonista receptor nicotìnico | |
ATE63818T1 (de) | 3'-azido-3'-deoxythymidin-formulierungen mit gesteuerter freigabe. | |
PA8443001A1 (es) | Prevencion de la perdida y restauracion de la masa osea por determinados agonistas de prostaglandinas | |
BR0113961A (pt) | Método de analgesia | |
HUP0103255A2 (hu) | Mitokondriális betegségek kezelésére szolgáló eljárások és készítmények | |
ES2188666T3 (es) | Analogos de la distamicina utilies como agentes antitumorales o antivirales. | |
ES2111925T3 (es) | Piridinas herbicidas sustituidas con heterociclos. | |
HUP9801571A2 (hu) | Zidovudin, 1592U89 és 3TC vagy FTC szinergetikus kombinációi | |
KR960701051A (ko) | 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases) | |
BR9607109A (pt) | Emprego de 5'nucleosídeos substituidos para a formação de resisténcia no tratamento de citostáticos e medicamentos contendo estes nucleosídeos | |
BR9811876A (pt) | Uso de compostos contendo citidina e contendo citosina como tratamento para exposiçào a estimulante | |
FI970147A (fi) | Triatsoliyhdisteitä ja niiden käyttö dopamiini-D3-ligandeina | |
DE69521122D1 (de) | 2,3,4,5-tetrahydro-1h-3-benzazepin säure-additions-salze | |
NO953353D0 (no) | Xantinderivater som adenosin-A -reseptorantagonister | |
DK0865271T4 (da) | Anvendelse af 2-ethylhexyl alfa-cyano-beta, beta-diphenylacrylat med henblik på at forbedre stabiliteten over for lys af p-methylbenzyliden-kamfer | |
DE69914757D1 (de) | Parfümzusammensetzung | |
BR0316054A (pt) | Compostos para tratamento de dependência e privação de tabaco | |
DK0722325T3 (da) | Præparat til behandling eller forebyggelse af herpes | |
MX9305016A (es) | Metodo para inhibir la replicacion hiv utilizando il-4. | |
DE60207824D1 (de) | Cytidin-diphosphocholin gegen diabetische neuropathie | |
NO950388L (no) | Kontrollert frigjorte farmasöytiske formuleringer av 3'-azido-3'-deoksythythymidin og metoder for anvendelse | |
ES2085023T3 (es) | Procedimientos para la produccion de zidovudina. | |
SE9001592L (sv) | Terapeutisk komposition |